30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jim Mullen

Track

Insider profile

Currently holds positions in Thermo Fisher Scientific Inc and Editas Medicine Inc

Performance

Overall performance
2.4
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 49% 68% 82%
Transactions
4 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -29%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Director Thermo Fisher Scientific Inc Nov. 8, 2018 -
Independent Chairman of the Board Editas Medicine Inc March 27, 2018 -
Independent Director Insulet Corp Aug. 9, 2017 - Jan. 25, 2019
Independent Director Revvity Inc Jan. 1, 2004 - April 28, 2015
Jim Mullen's trades of Editas Medicine Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-01-04 2022-01-03
S Sale
54,675 +34.6%
385.90
US$3,441,349 		54,675 +34.6% 385.90 US$3,441,349
2021-10-20 2021-10-18
S Sale
82,280 -35.3%
194.06
US$4,186,388 		82,280 -35.3% 194.06 US$4,186,388
2021-03-04 2021-03-02
B Purchase
11,817 -4.6%
389.90
US$780,349 		11,817 -4.6% 389.90 US$780,349
2004-10-20 2004-10-18
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -3.8%
57.81
US$86,711 		1,500 -3.8% 57.81 US$86,711
2004-10-20 2004-10-18
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -3.7%
58.05
US$87,073 		1,500 -3.7% 58.05 US$87,073
2004-10-20 2004-10-18
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -3.6%
57.50
US$86,250 		1,500 -3.6% 57.50 US$86,250
2004-10-13 2004-10-11
US Biogen Inc (BIIB)
PlS Planned sale
1,000 -2.3%
60.00
US$60,000 		1,000 -2.3% 60.00 US$60,000
2004-10-13 2004-10-11
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -3.4%
59.95
US$89,925 		1,500 -3.4% 59.95 US$89,925
2004-10-13 2004-10-11
US Biogen Inc (BIIB)
PlS Planned sale
1,325 -2.9%
60.33
US$79,937 		1,325 -2.9% 60.33 US$79,937
2004-10-13 2004-10-11
US Biogen Inc (BIIB)
PlS Planned sale
175 -100.0%
60.33
US$10,558 		175 -100.0% 60.33 US$10,558
2004-10-13 2004-10-11
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -89.6%
60.12
US$90,180 		1,500 -89.6% 60.12 US$90,180
2004-10-05 2004-10-04
US Biogen Inc (BIIB)
PlS Planned sale
1,000 -37.4%
62.38
US$62,380 		1,000 -37.4% 62.38 US$62,380
2004-10-05 2004-10-04
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -35.9%
62.77
US$94,158 		1,500 -35.9% 62.77 US$94,158
2004-10-05 2004-10-04
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -26.4%
62.85
US$94,268 		1,500 -26.4% 62.85 US$94,268
2004-10-05 2004-10-04
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -20.9%
62.48
US$93,723 		1,500 -20.9% 62.48 US$93,723
2004-07-27 2004-07-26
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.6%
53.44
US$80,157 		1,500 -2.6% 53.44 US$80,157
2004-07-27 2004-07-26
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.5%
53.35
US$80,025 		1,500 -2.5% 53.35 US$80,025
2004-07-27 2004-07-19
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.6%
53.51
US$80,259 		1,500 -2.6% 53.51 US$80,259
2004-07-20 2004-07-19
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.4%
57.96
US$86,933 		1,500 -2.4% 57.96 US$86,933
2004-07-20 2004-07-19
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.4%
57.90
US$86,849 		1,500 -2.4% 57.90 US$86,849
2004-07-20 2004-07-19
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.3%
57.92
US$86,877 		1,500 -2.3% 57.92 US$86,877
2004-07-15 2004-07-13
US Biogen Inc (BIIB)
PlS Planned sale
1,000 -1.5%
60.70
US$60,700 		1,000 -1.5% 60.70 US$60,700
2004-07-15 2004-07-13
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.2%
60.50
US$90,755 		1,500 -2.2% 60.50 US$90,755
2004-07-15 2004-07-13
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.2%
60.48
US$90,723 		1,500 -2.2% 60.48 US$90,723
2004-07-15 2004-07-13
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.1%
60.69
US$91,037 		1,500 -2.1% 60.69 US$91,037
2004-07-09 2004-07-06
US Biogen Inc (BIIB)
PlS Planned sale
1,000 -1.4%
62.07
US$62,070 		1,000 -1.4% 62.07 US$62,070
2004-07-09 2004-07-06
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -2.1%
61.99
US$92,985 		1,500 -2.1% 61.99 US$92,985
2004-07-09 2004-07-06
US Biogen Inc (BIIB)
PlS Planned sale
925 -1.3%
61.98
US$57,335 		925 -1.3% 61.98 US$57,335
2004-07-09 2004-07-06
US Biogen Inc (BIIB)
PlS Planned sale
575 -100.0%
61.98
US$35,641 		575 -100.0% 61.98 US$35,641
2004-07-09 2004-07-06
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -72.3%
63.97
US$95,959 		1,500 -72.3% 63.97 US$95,959
2004-05-26 2004-05-24
US Biogen Inc (BIIB)
PlS Planned sale
1,000 -3.3%
61.32
US$61,320 		1,000 -3.3% 61.32 US$61,320
2004-05-26 2004-05-24
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -4.7%
61.29
US$91,932 		1,500 -4.7% 61.29 US$91,932
2004-05-26 2004-05-24
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -4.5%
61.26
US$91,896 		1,500 -4.5% 61.26 US$91,896
2004-05-26 2004-05-24
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -4.3%
61.37
US$92,050 		1,500 -4.3% 61.37 US$92,050
2004-05-14 2004-05-14
US Revvity Inc (RVTY)
B Purchase
5,000 +124.4%
18.33
US$91,650 		5,000 +124.4% 18.33 US$91,650